Dolominol a and B, two new neolignans from Dolomiaea souliei (Franch.) C.Shih
- Nat Prod Res. 2022 Aug;36(15):3909-3916. doi: 10.1080/14786419.2021.1897125.
- 1. College of Pharmaceutical Sciences, Southwest University, Chongqing, P.R. China.
- 2. School of Life Sciences, Southwest University, Chongqing, P.R. China.
Two new neolignans, dolominol A (1) and dolominol B (2), together with 12 known Lignans, erythro-(7S,8R)-guaiacyl-glycerol-β-O-4'-dihydroconiferyl ether (3), threo-(7R,8R)-1-(4-hydroxy-3-methoxyphenyl)-2-{4-[(E)-3-hydroxy-1-propenyl)]-2-methoxyphenoxy}-1,3-propanediol (4), (-)-dihydrodehydrodiconiferyl alcohol (5), (-)-massoniresinol (6), vladinol D (7), syringaresinol (8), prinsepiol (9), medioresinol (10), (+)-pinoresinol (11), 2α-guaicyl-4-oxo-6α-catechyl-3,7-dioxabicyclo [3.3.0]octane (12), cycloolivil (13), isolariciresinol (14) were isolated from Dolomiaea souliei (Franch.) C.Shih. Their structures were determined by UV, CD, HR-ESI-TOFMS, 1 D and 2 D NMR experiments. Their hepatoprotective effect against LPS-induced L-02 cells injury was also studied. Result revealed that compound 4 showed best protective effect on LPS-induced L-02 cells.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: OthersResearch Areas: Metabolic Disease